ArticleJACC. Case reports2025
Prosthetic Mitral Valve Fungal Endocarditis: Challenges in Diagnosis and Management.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fungal prosthetic valve endocarditis is described in a patient without significant comorbidities. Key questions guiding the discussion include the following. 1) What are the diagnostic criteria and major differential diagnoses? 2)What are the current surgical indications and optimal timing for prosthetic valve endocarditis? 3) How do mortality prediction scores inform surgical decision-making through risk stratification? 4) What medical treatment should be initiated, and what is the most appropriate antifungal regimen once the etiologic agent is identified? 5) What strategies ensure long-term follow-up and prevention of postoperative fungal reinfection? After initial antibiotic failure, the patient underwent successful reoperation, leading to the diagnosis of fungal infection, which was appropriately treated with antifungal therapy. TAKE-HOME MESSAGES: This case underscores the complexity of diagnosing fungal endocarditis and its high mortality risk, highlighting the critical role of a multidisciplinary team in achieving optimal management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.